FBT outperforms IBB by focusing on smaller biotech firms, offering higher returns but more volatility.
The First Trust NYSE Arca Biotechnology Index Fund (FBT) and the iShares Biotechnology ETF (IBB) differ significantly in strategy and performance. FBT uses an equal-weight approach across about 30 biotech stocks, emphasizing innovation and smaller co...
